Protocol Ledger

NCT04620161 · Phase II · COMPLETED

A Proof of Concept Study of Pradigastat in Patients With Functional Constipation

Interventional Phase II clinical trial protocol NCT04620161 sponsored by Anji Pharma in Gastroenterology, Hepatology, and Renal, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2020-09-22 Enrollment: 181 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT04620161
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)181 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04620161
Protocol FieldVerified Registry Value
NCT IdentifierNCT04620161
Consolidated Lead SponsorAnji Pharma
Therapeutic Condition CohortGastroenterology, Hepatology, and Renal
Clinical Trial PhasePhase II
Overall Recruitment StatusCOMPLETED
Registered Enrollment181 participants (ACTUAL)
Registered Start Date2020-09-22
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Gastroenterology, Hepatology, and Renal Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI